Story perspectives

Health Canada Recalls Amlodipine Due to Dangerous Mix-Up

2/9/2026

Summary

Story summary

Health Canada has recalled MAR-Amlodipine 5 mg tablets after a mix-up that could place midodrine 2.5 mg tablets in some bottles.
The error poses health risks, including dangerously high blood pressure, dizziness, fainting, and potential organ damage.
Children are particularly at risk if they ingest the incorrect medication.
The MAR-Amlodipine tablets are white to off-white, eight-sided, marked with “210” and “5”; mispackaged midodrine tablets are round and marked “M2.”

1 of 1

Story summary

Health Canada has recalled MAR-Amlodipine 5 mg tablets after a mix-up that could place midodrine 2.5 mg tablets in some bottles.
The error poses health risks, including dangerously high blood pressure, dizziness, fainting, and potential organ damage.
Children are particularly at risk if they ingest the incorrect medication.
The MAR-Amlodipine tablets are white to off-white, eight-sided, marked with “210” and “5”; mispackaged midodrine tablets are round and marked “M2.”